InvestorQ : What is your view on Dr. Reddy Laboratories after the latest quarterly results for Mar-21?
ishika Banerjee made post

What is your view on Dr. Reddy Laboratories after the latest quarterly results for Mar-21?

Answer
image
1 month ago
Follow

For the Mar-21 quarter, Dr. Reddy’s Laboratories reported 29% lower net profits at Rs.557 crore with top line revenues higher by 7% at Rs.4,768 crore. However, this was largely due to a deferred tax recognition in the quarter, which was a one-time debit. For the FY21 period, the net profit fell by about 3.5% to Rs.1,952 crore. Reddy Labs is playing a big role in introducing the Russian Sputnik-V vaccine in India apart from commercialization of drugs.

Reddy Laboratories declared a final dividend of Rs.25 per equity share for the financial year 2020-21.

2 Views